Type 1 Diabetes (T1D) Market Report

China Type 1 Diabetes (T1D) Industry Market Research Report 2023-2029

  • POSTDATE：Oct 11, 2023
  • PAGES：157
  • REPORT CODE：GMM1843563
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Type 1 Diabetes (T1D) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bristol-Myers Squibb

    • Janssen

    • Astellas

    • Biocon

    • Boehringer Ingelheim

    • Sanofi

    • Lexicon

    • Merck

    • Novo Nordisk

    By Type:

    • Rapid Acting Insulin Analogs

    • Long Acting Insulin Analogs

    • Premix Insulin Analogs

    By Application:

    • Children

    • Adults

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Type 1 Diabetes (T1D) Market Overview 2018-2029

    • 1.1 China Type 1 Diabetes (T1D) Industry Development Overview

    • 1.2 China Type 1 Diabetes (T1D) Industry Development History

    • 1.3 China Type 1 Diabetes (T1D) Industry Market Size (2018-2029)

    • 1.4 China Type 1 Diabetes (T1D) Market Analysis by Type from Production Side

      • 1.4.1 China Type 1 Diabetes (T1D) Production Volume, Production Value and Growth Rate of Rapid Acting Insulin Analogs (2018-2029)

      • 1.4.2 China Type 1 Diabetes (T1D) Production Volume, Production Value and Growth Rate of Long Acting Insulin Analogs (2018-2029)

      • 1.4.3 China Type 1 Diabetes (T1D) Production Volume, Production Value and Growth Rate of Premix Insulin Analogs (2018-2029)

    • 1.5 China Type 1 Diabetes (T1D) Market Analysis by Application from Consumption End

      • 1.5.1 China Type 1 Diabetes (T1D) Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

      • 1.5.2 China Type 1 Diabetes (T1D) Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • 1.6 China Type 1 Diabetes (T1D) Market Analysis by Region

      • 1.6.1 North China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Type 1 Diabetes (T1D) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Type 1 Diabetes (T1D) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Type 1 Diabetes (T1D) Market Status and Competition Analysis in 2023

      • 2.2.3 China Type 1 Diabetes (T1D) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Type 1 Diabetes (T1D) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Type 1 Diabetes (T1D) Industry Development

    Chapter 3 Type 1 Diabetes (T1D)Industry Chain Analysis

    • 3.1 Type 1 Diabetes (T1D) Industry Chain

    • 3.2 Type 1 Diabetes (T1D) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Type 1 Diabetes (T1D) Market

    • 3.3 Type 1 Diabetes (T1D) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Type 1 Diabetes (T1D) Market

    Chapter 4 China Type 1 Diabetes (T1D) Market, by Type

    • 4.1 China Type 1 Diabetes (T1D) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Type 1 Diabetes (T1D) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Type 1 Diabetes (T1D) Production Volume and Growth Rate, by Type

      • 4.5.1 China Type 1 Diabetes (T1D) Production Volume and Growth Rate of Rapid Acting Insulin Analogs

      • 4.5.2 China Type 1 Diabetes (T1D) Production Volume and Growth Rate of Long Acting Insulin Analogs

      • 4.5.3 China Type 1 Diabetes (T1D) Production Volume and Growth Rate of Premix Insulin Analogs

    Chapter 5 China Type 1 Diabetes (T1D) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Type 1 Diabetes (T1D) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Type 1 Diabetes (T1D) Market Size and Growth Rate, by Application

      • 5.5.1 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Children

      • 5.5.2 China Type 1 Diabetes (T1D) Market Size and Growth Rate of Adults

    Chapter 6 China Type 1 Diabetes (T1D) Market, by Region

    • 6.1 China Type 1 Diabetes (T1D) Production Volume and Production Value, by Region

    • 6.2 China Type 1 Diabetes (T1D) Sales Volume and Sales Value, by Region

    Chapter 7 North China Type 1 Diabetes (T1D) Market Analysis

    • 7.1 North China Type 1 Diabetes (T1D) Market, by Type

    • 7.2 North China Type 1 Diabetes (T1D) Market, by Application

    Chapter 8 Central China Type 1 Diabetes (T1D) Market Analysis

    • 8.1 Central China Type 1 Diabetes (T1D) Market, by Type

    • 8.2 Central China Type 1 Diabetes (T1D) Market, by Application

    Chapter 9 South China Type 1 Diabetes (T1D) Market Analysis

    • 9.1 South China Type 1 Diabetes (T1D) Market, by Type

    • 9.2 South China Type 1 Diabetes (T1D) Market, by Application

    Chapter 10 East China Type 1 Diabetes (T1D) Market Analysis

    • 10.1 East China Type 1 Diabetes (T1D) Market, by Type

    • 10.2 East China Type 1 Diabetes (T1D) Market, by Application

    Chapter 11 Northeast China Type 1 Diabetes (T1D) Market Analysis

    • 11.1 Northeast China Type 1 Diabetes (T1D) Market, by Type

    • 11.2 Northeast China Type 1 Diabetes (T1D) Market, by Application

    Chapter 12 Southwest China Type 1 Diabetes (T1D) Market Analysis

    • 12.1 Southwest China Type 1 Diabetes (T1D) Market, by Type

    • 12.2 Southwest China Type 1 Diabetes (T1D) Market, by Application

    Chapter 13 Northwest China Type 1 Diabetes (T1D) Market Analysis

    • 13.1 Northwest China Type 1 Diabetes (T1D) Market, by Type

    • 13.2 Northwest China Type 1 Diabetes (T1D) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bristol-Myers Squibb

        • 14.1.1 Bristol-Myers Squibb Company Profile

        • 14.1.2 Bristol-Myers Squibb Type 1 Diabetes (T1D) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Janssen

        • 14.2.1 Janssen Company Profile

        • 14.2.2 Janssen Type 1 Diabetes (T1D) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Astellas

        • 14.3.1 Astellas Company Profile

        • 14.3.2 Astellas Type 1 Diabetes (T1D) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Biocon

        • 14.4.1 Biocon Company Profile

        • 14.4.2 Biocon Type 1 Diabetes (T1D) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Boehringer Ingelheim

        • 14.5.1 Boehringer Ingelheim Company Profile

        • 14.5.2 Boehringer Ingelheim Type 1 Diabetes (T1D) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi

        • 14.6.1 Sanofi Company Profile

        • 14.6.2 Sanofi Type 1 Diabetes (T1D) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Lexicon

        • 14.7.1 Lexicon Company Profile

        • 14.7.2 Lexicon Type 1 Diabetes (T1D) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Merck

        • 14.8.1 Merck Company Profile

        • 14.8.2 Merck Type 1 Diabetes (T1D) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Novo Nordisk

        • 14.9.1 Novo Nordisk Company Profile

        • 14.9.2 Novo Nordisk Type 1 Diabetes (T1D) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Type 1 Diabetes (T1D) Industry Research Conclusions

    • 15.2 Type 1 Diabetes (T1D) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Type 1 Diabetes (T1D) Industry Market Size (2018-2029)

    • Figure China Type 1 Diabetes (T1D) Production Volume, Production Value and Growth Rate of Rapid Acting Insulin Analogs (2018-2029)

    • Figure China Type 1 Diabetes (T1D) Production Volume, Production Value and Growth Rate of Long Acting Insulin Analogs (2018-2029)

    • Figure China Type 1 Diabetes (T1D) Production Volume, Production Value and Growth Rate of Premix Insulin Analogs (2018-2029)

    • Figure China Type 1 Diabetes (T1D) Sales Volume, Sales Value and Growth Rate of Children (2018-2029)

    • Figure China Type 1 Diabetes (T1D) Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • Figure North China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure Central China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure South China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure East China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Type 1 Diabetes (T1D) Market Size and Growth Rate from 2018-2029

    • Figure Type 1 Diabetes (T1D) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Type 1 Diabetes (T1D) Market Share by Type in 2018

    • Figure China Type 1 Diabetes (T1D) Market Share by Type in 2023

    • Figure China Type 1 Diabetes (T1D) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Production Volume and Growth Rate of Rapid Acting Insulin Analogs (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Production Volume and Growth Rate of Long Acting Insulin Analogs (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Production Volume and Growth Rate of Premix Insulin Analogs (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Market Share by Application in 2018

    • Figure China Type 1 Diabetes (T1D) Market Share by Application in 2023

    • Figure China Type 1 Diabetes (T1D) Total Market Size and Growth Rate from Consumption End

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Children (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Market Size and Growth Rate of Adults (2018-2023)

    • Table China Type 1 Diabetes (T1D) Production Volume by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Production Volume Share by Region (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Production Volume Share by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Production Value by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Production Value Share by Region (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Production Value Share by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Sales Volume by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Sales Volume Share by Region (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Sales Volume Share by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Sales Value by Region (2018-2023)

    • Table China Type 1 Diabetes (T1D) Sales Value Share by Region (2018-2023)

    • Figure China Type 1 Diabetes (T1D) Sales Value Share by Region (2018-2023)

    • Table North China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table North China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure North China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table North China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table North China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure North China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table Central China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table Central China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure Central China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table Central China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table Central China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure Central China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table South China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table South China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure South China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table South China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table South China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure South China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table East China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table East China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure East China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table East China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table East China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure East China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table Northeast China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table Northeast China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table Northeast China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table Southwest China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table Southwest China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table Southwest China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Type 1 Diabetes (T1D) Production Volume by Type (2018-2023)

    • Table Northwest China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Type 1 Diabetes (T1D) Production Volume Share by Type (2018-2023)

    • Table Northwest China Type 1 Diabetes (T1D) Sales Volume by Application (2018-2023)

    • Table Northwest China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Type 1 Diabetes (T1D) Sales Volume Share by Application (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Janssen Company Profile

    • Table Janssen Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Astellas Company Profile

    • Table Astellas Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Lexicon Company Profile

    • Table Lexicon Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)

    • Table Novo Nordisk Company Profile

    • Table Novo Nordisk Type 1 Diabetes (T1D) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US